Table 6 Multivariate Cox regression analysis of factors affecting overall survival
From: Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma
Prognostic factor | p-value | Hazard ratio | 95% Confidence intervals |
|---|---|---|---|
Age | 0.115 | 1.036 | 0.991–1.083 |
TNM Stage | < 0.001 |  |  |
 Stage I vs Stage III | 0.011 | 0.062 | 0.007–0.534 |
 Stage II vs Stage III | < 0.001 | 0.154 | 0.058–0.409 |
Nottingham grade | 0.360 | Â | Â |
 Grade 2 vs Grade 1 | 0.164 | 0.447 | 0.144–1.388 |
 Grade 3 vs Grade 1 | 0.637 | 0.766 | 0.253–2.319 |
Margin involvement (Involved vs Uninvolved) | 0.578 | 1.430 | 0.405–5.052 |
Molecular subtype | 0.396 | Â | Â |
 HER 2 vs Luminal | 0.456 | 0.505 | 0.084–3.042 |
 TNBC vs Luminal | 0.509 | 1.624 | 0.386–6.833 |
ER/AR Status | 0.051 | Â | Â |
 ER+/AR- vs ER+/AR+ | 0.015 | 5.500 | 1.395–21.685 |
 ER−/AR+ vs ER+/AR+ | 0.050 | 5.049 | 1.001–25.457 |
 ER−/AR- vs ER+/AR+ | 0.345 | 2.256 | 0.417–12.207 |